Published in Am Heart J on February 01, 1987
Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function. JAMA Neurol (2014) 3.39
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study. Circ Cardiovasc Genet (2010) 1.77
Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res (2010) 1.63
Mining genetic epidemiology data with Bayesian networks application to APOE gene variation and plasma lipid levels. J Comput Biol (2005) 1.15
Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels. Am J Hum Genet (1989) 1.12
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet (2004) 1.07
Review: Transport of maternal cholesterol to the fetal circulation. Placenta (2011) 1.06
Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet (1989) 0.99
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes. Eur J Hum Genet (2008) 0.95
Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus. J Clin Pathol (1995) 0.90
Lipoprotein metabolism in nonalcoholic fatty liver disease. J Biomed Res (2012) 0.90
Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest (1996) 0.88
Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci (1996) 0.88
Are centenarians genetically predisposed to lower disease risk? Age (Dordr) (2011) 0.87
Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord (2005) 0.83
Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry (1994) 0.83
Apo E gene polymorphism affects development of type 2 diabetic nephropathy in Asian populations, especially in East Asians: an updated meta-analysis. Med Sci Monit (2014) 0.82
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut (1999) 0.82
Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome. Mol Genet Metab (2008) 0.80
Maternal ABCA1 genotype is associated with severity of Smith-Lemli-Opitz syndrome and with viability of patients homozygous for null mutations. Eur J Hum Genet (2012) 0.80
Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients. Lipids Health Dis (2014) 0.79
Severe xanthomatosis associated with familial apolipoprotein E deficiency. J Clin Pathol (1996) 0.79
Pharmacogenomics and cardiovascular disease. Curr Cardiol Rep (2013) 0.79
Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey. J Assist Reprod Genet (2008) 0.78
Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity. Clin Exp Nephrol (2007) 0.77
Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+. BMC Geriatr (2004) 0.77
Apolipoprotein E phenotypes and cardiovascular responses to experimentally induced mental stress in adolescent boys. J Behav Med (1997) 0.77
Apolipoproteins in lipid transport, an impressionist view. Postgrad Med J (1989) 0.76
Apolipoprotein polymorphism and multifactorial hyperlipidaemia. J Inherit Metab Dis (1988) 0.76
MTHFR gene C677T polymorphism and type 2 diabetic nephropathy in Asian populations: a meta-analysis. Int J Clin Exp Med (2015) 0.76
Association between Apolipoprotein E Polymorphism and Chronic Kidney Disease in the Korean General Population: Dong-gu Study. Korean J Fam Med (2014) 0.75
Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis. PLoS One (2014) 0.75
Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients? Osteoporos Int (2003) 0.75
Cardiovascular drugs and the genetic response. Methodist Debakey Cardiovasc J (2014) 0.75
Interaction of apolipoprotein E genotype and dietary cholesterol in determining plasma cholesterol levels. Am J Hum Genet (1992) 0.75
Normal and pathological lipoprotein metabolism. Drugs (1988) 0.75
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature (1977) 3.04
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Studies on the amphipathic nature of the membrane proteins in Semliki Forest virus. J Mol Biol (1974) 2.37
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest (1987) 2.35
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration? Am J Hum Genet (1999) 2.25
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet (1979) 2.14
Lipoprotein(a): resurrected by genetics. J Intern Med (2012) 2.12
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88
Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett (1975) 1.87
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet (1988) 1.68
Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet (1979) 1.66
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet (1991) 1.59
Lipoprotein(a) in renal disease. Am J Kidney Dis (1996) 1.51
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem (1975) 1.39
Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet (1989) 1.34
Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett (1983) 1.32
Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem (1985) 1.27
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet (1992) 1.26
Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet (1984) 1.26
Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem (1983) 1.26
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol (1996) 1.20
An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem (1979) 1.18
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb (1992) 1.17
Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Hum Genet (1982) 1.14
Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem (1990) 1.14
Sensorineural hearing loss and the incidence of Cx26 mutations in Austria. Eur J Hum Genet (2001) 1.10
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur J Immunol (1999) 1.09
Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. Eur J Hum Genet (2001) 1.09
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet (2004) 1.07
Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2000) 1.07
T cell expressed PKCtheta demonstrates cell-type selective function. Eur J Immunol (2000) 1.04
Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D. FEBS Lett (1979) 1.04
Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene. Hum Genet (1990) 1.02
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest (1992) 1.01
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia. Metabolism (1981) 1.01
Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A (1993) 1.01
Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res (1994) 1.01
Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem (1979) 1.01
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet (2001) 1.00
Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet (1996) 1.00
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1995) 0.99
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest (1995) 0.99
Detection of a de novo duplication of 1q32-qter by fluorescence in situ hybridisation in a boy with multiple malformations: further delineation of the trisomy 1q syndrome. J Med Genet (1997) 0.99
Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet (1986) 0.98
Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis. J Lipid Res (1984) 0.97
The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6. Hum Genet (1989) 0.97
Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III). Clin Genet (1977) 0.96
Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet (1984) 0.96
Mutations in the human DHCR7 gene. Hum Mutat (2001) 0.96
Cloning, structural analysis, and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2. Genomics (1997) 0.96
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. J Med Genet (2007) 0.96
Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI. Hum Genet (1982) 0.96
Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation. Clin Genet (1978) 0.96
Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet (1999) 0.96
The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem (1996) 0.96
The membrane proteins of Semliki Forest virus have a hydrophobic part attached to the viral membrane. FEBS Lett (1972) 0.95
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem (1982) 0.95
Whole genome amplification from microdissected chromosomes. Cytogenet Genome Res (2009) 0.95
Split hand/split foot malformation associated with sensorineural deafness, inner and middle ear malformation, hypodontia, congenital vertical talus, and deletion of eight microsatellite markers in 7q21.1-q21.3. J Med Genet (2001) 0.95
Mapping of the human protein kinase C-theta (PRKCQ) gene locus to the short arm of chromosome 10 (10p15) by FISH. Genomics (1995) 0.93
Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis (1988) 0.92
Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Hum Mutat (2005) 0.92
Substitution in vitro of lecithin-cholesterol acyltransferase. Analysis of changes in plasma lipoproteins. Eur J Biochem (1980) 0.92
Lipoproteins in LCAT-deficiency. Humangenetik (1972) 0.92
Routine screening for microdeletions by FISH in 77 patients suspected of having Prader-Willi or Angelman syndromes using YAC clone 273A2 (D15S10). Hum Genet (1996) 0.92
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet (1992) 0.92
Allele-specific competitive blocker PCR: a one-step method with applicability to pool screening. Hum Mutat (1995) 0.91
Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians. Hum Mol Genet (1999) 0.90
Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet (1998) 0.89
Hypomelanosis of Ito in a girl with plexus papilloma and translocation (X;17). Hum Genet (1993) 0.89
Molecular genetics of type 1 glycogen storage disease. Mol Genet Metab (2001) 0.89
Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis. Adv Exp Med Biol (1985) 0.89
High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet (1995) 0.88
Herpes simplex virus binds to human serum lipoprotein. Intervirology (1988) 0.88
Parental origin of de novo cytogenetically balanced reciprocal non-Robertsonian translocations. Cytogenet Genome Res (2012) 0.88
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA (1997) 0.87
The seventh myth of lipoprotein(a): where and how is it assembled? Curr Opin Lipidol (1999) 0.86
DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome. Clin Genet (2004) 0.86
De novo mutation of the connexin 26 gene associated with dominant non-syndromic sensorineural hearing loss. Hum Genet (2001) 0.86
Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III). Ric Clin Lab (1982) 0.86
Studies on the Lp(a)-lipoprotein of human serum. IV. The disaggregation of the Lp(a)-lipoprotein. Humangenetik (1972) 0.86
Schnyder's dystrophy. Progression and metabolism. Ophthalmic Paediatr Genet (1986) 0.86
Homozygosity for the W151X stop mutation in the delta7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: retrospective molecular diagnosis. Am J Med Genet (2000) 0.85
Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). Kidney Int (1998) 0.85
Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins. Humangenetik (1975) 0.85
Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies. N Engl J Med (1982) 0.85
Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol (1996) 0.85
Automatic separation of two PCRs in one tube by annealing temperature. Trends Genet (1995) 0.85